OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares

Summary by AI BETAClose X

OKYO Pharma has priced a public offering of 10,815,000 ordinary shares at $1.85 per share, expecting to raise approximately $20 million in gross proceeds before expenses. The company has also granted the underwriter a 30-day option to purchase an additional 1,622,250 shares, which could increase gross proceeds to around $23 million. These net proceeds are intended for the clinical development of its product candidates, general corporate purposes, and working capital. The offering is expected to close on or about February 17, 2026.

Disclaimer*

UK 100

Latest directors dealings